Afuco™ Anti-MUC5AC ADCC Recombinant Antibody, ADCC Enhanced (AFC-TAB-200) (CAT#: AFC-TAB-200)

This product is an ADCC enhanced antibody produced by our Afuco™ platform. Recombinant monoclonal antibody to 5AC. It is a chimeric monoclonal antibody used in the treatment of cancers.

Specific Inquiry
  • Size:
  • Conjugation:
  • Endotoxin:
  • Purity:
  • Fc Engineering:
  • Gene Expression
  • Datasheet
  • MSDS
  • COA
Normal Tissue
RNA Expression

Specifications

  • Immunogen
  • M1 mucin preparation from the fluid of an ovarian mucinous cyst.
  • Host Species
  • Chimeric
  • Derivation
  • Chimeric (mouse/human)
  • Type
  • ADCC enhanced antibody
  • Species Reactivity
  • Human
  • Applications
  • IP, IF, FuncS, FC, Neut, ELISA
  • Conjugate
  • Unconjugated
  • Generic Name
  • Ensituximab
  • Related Disease
  • Colorectal cancers

Product Property

  • Purity
  • >95% by SDS-PAGE
  • Storage
  • Store at +4°C short term (1-2 weeks). Aliquot and store at -20°C long term. Avoid repeated freeze/thaw cycles.

Target

  • Alternative Names
  • MUC5AC; mucin 5AC, oligomeric mucus/gel-forming; mucin 5, subtypes A and C, tracheobronchial/gastric; mucin-5AC; MUC5; gastric mucin; tracheobronchial mucin; major airway glycoprotein; lewis B blood group antigen

Related Resources

  • Biosimilar Overview
Please refer to Ensituximab Overview to learn more about the mechanism of action, clinical projects, and approved drugs of Ensituximab.

Product Notes

This is a product of Creative Biolabs' Hi-Affi™ recombinant antibody portfolio, which has several benefits including:

• Increased sensitivity
• Confirmed specificity
• High repeatability
• Excellent batch-to-batch consistency
• Sustainable supply
• Animal-free production

See more details about Hi-Affi™ recombinant antibody benefits.

Downloads

Download resources about recombinant antibody development and antibody engineering to boost your research.

See other products for "Ensituximab"

DrugMonitor™ Anti-Ensituximab Antibody (VS-1224-YC429)
Ensituximab (NEO-102) is a novel chimeric mAb targeting a glycosylated MUC5AC variant, specific to colorectal and pancreatic cancers. The DrugMonitor™ Anti-Ensituximab Antibody (VS-1224-YC429) is an anti-drug antibody (ADA) against Ensituximab. This drug-based antibody is raised in mice immunized with the Ensituximab. The anti-Ensituximab antibody may be used in ELISA, pharmacokinetics (PK), and pharmacodynamics (PD) analyses, or serves as a reference standard in ADA assays. It also is an excellent tool for therapeutic drug monitoring, allowing to evaluate the drug efficacy and determine the drug concentration of the Ensituximab in samples.

See other products for "MUC5AC"

Select a product category from the dropdown menu below to view related products.
Please select product type
IgG Antibody Products Chimeric Antibody Products Mouse Antibody Products Humanized Antibody Products Epitope-Specific Antibody Products ScFv Antibody Products Fab Antibody Products MHC Tetramer Products for Cancer Non-Human Primate (NHP) Antibody Products

Customer Reviews and Q&As

Submit a review or a question

There are currently no Customer reviews or questions for AFC-TAB-200. Click the button above to contact us or submit your feedback about this product.

Popular products with customers


For Research Use Only. Not For Clinical Use.

For research use only. Not intended for any clinical use. No products from Creative Biolabs may be resold, modified for resale or used to manufacture commercial products without prior written approval from Creative Biolabs.

Send Inquiry

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

  • 0
  • 0
Cart
    Go to compare

    Go to compare